IVF denied as non-formulary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Issues Non-Formulary Denials in the Context of IVF — and What to Do

In the IVF context, a "non-formulary" denial from a BlueCross BlueShield plan almost always targets the fertility medications prescribed as part of the IVF protocol — such as injectable gonadotropins, GnRH agonists or antagonists, progesterone support agents, or human chorionic gonadotropin trigger medications — rather than the IVF procedure itself. BCBS may place these medications on a non-preferred formulary tier requiring higher cost-sharing, require substitution of a preferred formulary alternative, or exclude them from the pharmacy benefit while covering them differently (or not at all) under the medical benefit.

Because BCBS is a federation of independent affiliates, formulary structures differ by state and employer plan. Always obtain your specific BCBS affiliate's formulary and pharmacy benefit design documents before filing.

## Your Federal Appeal Rights

• Internal appeal: You are entitled to a full internal review under ERISA §503 (self-funded) or state insurance law (fully insured). This includes the right to request a formulary exception prior to or alongside a formal appeal.
• Formulary exception process: BCBS plans are required to have a formulary exception procedure. Your prescriber can submit a formulary exception request documenting why the preferred formulary alternative is not clinically appropriate for your specific IVF protocol.
• External review (ACA §2719): After exhausting internal processes, independent external review is available within approximately 4 months (180 days) of the denial. Expedited review is available if delay poses a medical risk.

## The Concrete Appeal Process

1. Identify the exact denial scope: Confirm whether the denial is a tier placement (higher cost-sharing only), a step-therapy requirement (try a preferred agent first), or a hard formulary exclusion. 2. Request a formulary exception through BCBS — have your reproductive endocrinologist complete the exception form, documenting why the specific agent is necessary for your protocol and why formulary alternatives are not clinically interchangeable. 3. Cross-check the medical benefit: If the pharmacy benefit excludes a medication, confirm whether the same agent administered in a clinical setting may be billable under the medical benefit. 4. File a Level 1 internal appeal if the exception is denied, attaching the prescriber's letter and supporting clinical documentation. 5. Escalate to external review if the internal appeal is upheld.

## Documentation to Gather

• Prescriber letter: A detailed letter from your reproductive endocrinologist explaining why the prescribed medication is necessary for your specific protocol and why any formulary-preferred alternative is not clinically appropriate — for example, due to your response history, ovarian reserve profile, or protocol design per ASRM guidance.
• Prior response or treatment records: If you have undergone prior cycles, records documenting your response to medications previously used.
• BCBS formulary and exception criteria: Downloaded from your BCBS member portal, so your appeal responds to the exact language and criteria used.
• Infertility diagnosis and treatment history: Supporting the overall medical necessity of IVF and the specific medication protocol.

## Criteria-Mapping Structure

For each criterion in the formulary exception denial, provide a direct response backed by a dated chart note or prescriber attestation. The strongest formulary exception arguments show either that the preferred alternative was tried and failed in a prior cycle, or that a specific clinical characteristic of your case makes the preferred alternative inappropriate. Your prescriber's reference to the applicable ASRM guideline on protocol selection strengthens the argument considerably.